List of bibliographic references
Number of relevant bibliographic references: 19.
Ident. | Authors (with country if any) | Title |
---|
000225 (2001) |
Olivier Rascol ; Joaquim J. Ferreira ; Claire Thalamas ; Monique Galitsky ; Jean-Louis Montastruc | Dopamine agonists: Their role in the management of Parkinson's disease |
000280 (2003) |
Alan L. Whone ; Ray L. Watts ; A. Jon Stoessl ; Margaret Davis ; Sven Reske ; Claude Nahmias ; Anthony E. Lang ; Olivier Rascol ; Maria J. Ribeiro ; Philippe Remy ; Werner H. Poewe ; Robert A. Hauser ; David J. Brooks | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study |
000368 (2004) |
C. Warren Olanow ; Yves Agid ; Yoshi Mizuno ; Alberto Albanese ; U. Bonucelli ; Philip Damier ; Justo De Yebenes ; Oscar Gershanik ; Mark Guttman ; F. Grandas ; Mark Hallett ; Ole Hornykiewicz ; Peter Jenner ; R. Katzenschlager ; William J. Langston ; Peter Lewitt ; Eldad Melamed ; M. A. Mena ; P. P. Michel ; Catherine Mytilineou ; Jose A. Obeso ; Werner Poewe ; Niall Quinn ; R. Raisman-Vozari ; Ali H. Rajput ; Olivier Rascol ; Christina Sampaio ; Fabrizio Stocchi | Levodopa in the treatment of Parkinson's disease: Current controversies |
000532 (2006) |
Olivier Rascol ; David J. Brooks ; Amos D. Korczyn ; Peter P. De Deyn ; Carl E. Clarke ; Anthony E. Lang ; Mona Abdalla | Development of dyskinesias in a 5-year trial of ropinirole and L-dopa |
000554 (2007) |
Christopher G. Goetz ; Stanley Fahn ; Pablo Martinez-Martin ; Werner Poewe ; Cristina Sampaio ; Glenn T. Stebbins ; Matthew B. Stern ; Barbara C. Tilley ; Richard Dodel ; Bruno Dubois ; Robert Holloway ; Joseph Jankovic ; Jaime Kulisevsky ; Anthony E. Lang ; Andrew Lees ; Sue Leurgans ; Peter A. Lewitt ; David Nyenhuis ; C. Warren Olanow ; Olivier Rascol ; Anette Schrag ; Jeanne A. Teresi ; Jacobus J. Van Hilten ; Nancy Lapelle | Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS) : Process, format, and clinimetric testing plan |
000646 (2007) |
Robert A. Hauser ; Olivier Rascol ; Amos D. Korczyn ; A. Jon Stoessl ; Ray L. Watts ; Werner Poewe ; Peter P. De Deyn ; Anthony E. Lang | Ten-Year Follow-Up of Parkinson's Disease Patients Randomized to Initial Therapy with Ropinirole or Levodopa |
000707 (2008) |
C. Warren Olanow ; Robert A. Hauser ; Joseph Jankovic ; William Langston ; Anthony Lang ; Wemer Poewe ; Eduardo Tolosa ; Fabrizio Stocchi ; Eldad Melamed ; Eli Eyal ; Olivier Rascol | A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline as a Disease Modifying Therapy in Parkinson's Disease (The ADAGIO Study) : Rationale, Design, and Baseline Characteristics |
000708 (2008) |
Christopher G. Goetz ; Barbara C. Tilley ; Stephanie R. Shaftman ; Glenn T. Stebbins ; Stanley Fahn ; Pablo Martinez-Martin ; Wemer Poewe ; Cristina Sampaio ; Matthew B. Stem ; Richard Dodel ; Bruno Dubois ; Robert Holloway ; Joseph Jankovic ; Jaime Kulisevsky ; Anthony E. Lane ; Andrew Lees ; Sue Leurgans ; Peter A. Le Witt ; David Nyenhuis ; C. Warren Olanow ; Olivier Rascol ; Anette Schrag ; Jeanne A. Teresi ; Jacobus J. Van Hilten ; Nancy Lapelle | Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) : Scale Presentation and Clinimetric Testing Results |
000779 (2009) |
C. Warren Olanow ; Olivier Rascol ; Robert Hauser ; Paul D. Feigin ; Joseph Jankovic ; Anthony Lang ; William Langston ; Eldad Melamed ; Werner Poewe ; Fabrizio Stocchi ; Eduardo Tolosa | A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease |
000835 (2010) |
Juliana Bronzova ; Cristina Sampaio ; Robert A. Hauser ; Anthony E. Lang ; Olivier Rascol ; Ad Theeuwes ; Serge V. Van De Witte ; Guus Van Scharrenburg | Double-Blind Study of Pardoprunox, a New Partial Dopamine Agonist, in Early Parkinson's Disease |
000857 (2010) |
Fabrizio Stocchi ; Olivier Rascol ; Karl Kieburtz ; Werner Poewe ; Joseph Jankovic ; Eduardo Tolosa ; Paulo Barone ; Anthony E. Lang ; C. Warren Olanow | Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease: The STRIDE-PD Study |
000861 (2010) |
Carlo Colosimo ; Pablo Martinez-Martin ; Giovanni Fabbrini ; Robert A. Hauser ; Marcelo Merello ; Janis Miyasaki ; Werner Poewe ; Cristina Sampaio ; Olivier Rascol ; Glenn T. Stebbins ; Anette Schrag ; Christopher G. Goetz | Task Force Report on Scales to Assess Dyskinesia in Parkinson's Disease: Critique and Recommendations |
000947 (2011) |
Olivier Rascol ; Andres Lozano ; Matthew Stern ; Werner Poewe | Milestones in Parkinson's Disease Therapeutics |
000967 (2011) |
Cristina Sampaio ; Juliana Bronzova ; Robert A. Hauser ; Anthony E. Lang ; Olivier Rascol ; Serge V. Van De Witte ; Ad Theeuwes | Pardoprunox in Early Parkinson's Disease: Results from 2 Large, Randomized Double-Blind Trials |
000995 (2011) |
Susan H. Fox ; Regina Katzenschlager ; Shen-Yang Lim ; Bernard Ravina ; Klaus Seppi ; Miguel Coelho ; Werner Poewe ; Olivier Rascol ; Christopher G. Goetz ; Cristina Sampaio | The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Motor Symptoms of Parkinson's Disease |
000A03 (2011) |
Klaus Seppi ; Daniel Weintraub ; Miguel Coelho ; Santiago Perez-Lloret ; Susan H. Fox ; Regina Katzenschlager ; Eva-Maria Hametner ; Werner Poewe ; Olivier Rascol ; Christopher G. Goetz ; Cristina Sampaio | The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease |
000A32 (2012) |
Andrew Lees ; Stanley Fahn ; Karla M. Eggert ; Joseph Jankovic ; Anthony Lang ; Federico Micheli ; M. Maral Mouradian ; Wolfgang H. Oertel ; C. Warren Olanow ; Werner Poewe ; Olivier Rascol ; Eduardo Tolosa ; David Squillacote ; Dinesh Kumar | Perampanel, an AMPA Antagonist, Found to Have No Benefit in Reducing "Off" Time in Parkinson's Disease |
000A70 (2012) |
Olivier Rascol ; Joaquim Ferreira ; Laurence Negre-Pages ; Santiago Perez-Lloret ; Lucette Lacomblez ; Monique Galitzky ; Jean-Christophe Lemarie ; Jean-Christophe Corvol ; Jonathan M. Brotchie ; Laura Bossi | A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease |
000B87 (2014) |
Santiago Perez-Lloret ; María Ver Nica Rey ; James Crispo ; Daniel Krewski ; Marise Lapeyre-Mestre ; Jean-Louis Montastruc ; Olivier Rascol | Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i -k "RASCOL (Olivier)"
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i \
-Sk "RASCOL (Olivier)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Merge/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PascalFrancis
|étape= Merge
|type= indexItem
|index= FA11s1.i
|clé= RASCOL (Olivier)
}}
| This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 | ![](Common/icons/LogoDilib.gif) |